Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -24194.20% is 111% below its 1-year average of -11439.47%, near the low end of its 1-year range (-24194.20%–-8763.64%).
Reported quarterly EBITDA margin; no daily interpolation. Q3 FY2020 (2020-09-30): -14700.00%.
EBITDA MARGIN
-24194.20%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$47.47M
EBITDA Margin
22.86%
TTM Avg
-25.83%
3Y Avg
-102.29%
5Y Avg
-102.29%
Market Cap
$48.76M
EBITDA Margin
-30422.22%
TTM Avg
-16673.71%
3Y Avg
-8702.25%
5Y Avg
-6477.94%
Market Cap
$49.50M
EBITDA Margin
-108.45%
TTM Avg
-10676.44%
3Y Avg
-10454.97%
5Y Avg
-429870.64%
Market Cap
$45.16M
EBITDA Margin
-203.44%
TTM Avg
-129.78%
3Y Avg
-288.25%
5Y Avg
-438.27%
Market Cap
$49.06M
EBITDA Margin
-36.10%
TTM Avg
-7.86%
3Y Avg
4.76%
5Y Avg
-6.98%
Market Cap
$45.05M
EBITDA Margin
-148.02%
TTM Avg
-167.05%
3Y Avg
-193.51%
5Y Avg
-252.90%
Market Cap
$45.02M
EBITDA Margin
14.14%
TTM Avg
17.13%
3Y Avg
-2.79%
5Y Avg
-117.76%
Market Cap
$49.21M
EBITDA Margin
-40.79%
TTM Avg
-44.28%
3Y Avg
-63.47%
5Y Avg
-81.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Instil Bio, Inc. (TIL) | $47.09M | -24194.20% | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | 22.86% | -25.83% | -102.29% | -102.29% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | -30422.22% | -16673.71% | -8702.25% | -6477.94% |
| Apollomics, Inc. (APLM)vs › | $49.50M | -108.45% | -10676.44% | -10454.97% | -429870.64% |
| Celularity Inc. (CELU)vs › | $45.16M | -203.44% | -129.78% | -288.25% | -438.27% |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.06M | -36.10% | -7.86% | 4.76% | -6.98% |
| DarioHealth Corp. (DRIO)vs › | $45.05M | -148.02% | -167.05% | -193.51% | -252.90% |
| SANUWAVE Health Inc. (SNWV)vs › | $45.02M | 14.14% | 17.13% | -2.79% | -117.76% |
| TELA Bio, Inc. (TELA)vs › | $49.21M | -40.79% | -44.28% | -63.47% | -81.32% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.07M | -3807.96% | -2001.11% | -1442.90% | -1442.90% |
Gross Margin
0.0%
EBITDA Margin
-24194.2%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2020-09-30 | -14700.00% |
| 2020-06-30 | -10854.76% |
| 2020-03-31 | -8763.64% |
